S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|UPDATE: 10 stocks that are pushing the Nasdaq -2- (2015/2/23)|
|Apricus Biosciences Announces Year-End 2014 Update and 2015 Plans to Advance Its Clinical Pipeline and Further Commercialize Its Erectile Dysfunction Drug Vitaros(R) (2014/12/22)|
|Apricus Biosciences Announces First Patient Enrolled in Phase 2a Clinical Trial for RayVa(TM) in Patients With Raynaud's Phenomenon (2014/12/4)|
|Apricus Biosciences Appoints Barbara Troupin, M.D. as Chief Medical Officer (2014/12/15)|
|Apricus Biosciences Announces the Appointment of Catherine Bovenizer as Vice President of Finance, Chief Accounting Officer (2015/1/12)|
|Apricus Biosciences Expands Exclusive License Agreement With an Existing Partner to Market Vitaros(R) in Select Asia-Pacific Countries (2015/2/3)|
|Apricus Biosciences Announces Issuance of U.S. Patent for RayVa(TM) (2015/1/27)|
|Apricus Biosciences Announces $11 Million Registered Direct Offering With Sarissa Capital Management LP (2015/2/11)|
|Apricus Biosciences to Present at Biotech Showcase 2015 (2015/1/6)|
|Apricus Biosciences to Present at the 17th Annual BIO CEO & Investor Conference (2015/2/3)|
Click above to view more mutual fund data and stats for apri - Apricus Biosciences Inc.